Table of Contents
Chapter 1. Global Dysmenorrhea Treatment Market Executive Summary
1.1. Global Dysmenorrhea Treatment Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Diseases
1.3.2. By Therapeutic Class
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Dysmenorrhea Treatment Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Dysmenorrhea Treatment Market Dynamics
3.1. Market Drivers
3.1.1. Growing healthcare spending
3.1.2. Increasing consumer awareness and low-cost medications
3.1.3. Technological advancements
3.2. Market Challenges
3.2.1. Side effects of long-term treatments
3.2.2. High morbidity leading to inadequate treatments
3.2.3. Traditional family values
3.3. Market Opportunities
3.3.1. Introduction of portable and advanced DMAs
3.3.2. Government initiatives and aging population
3.3.3. Increased disposable income and urbanization
Chapter 4. Global Dysmenorrhea Treatment Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Dysmenorrhea Treatment Market Size & Forecasts by Diseases 2022-2032
5.1. Segment Dashboard
5.2. Global Dysmenorrhea Treatment Market: Diseases Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.2.1. Primary Dysmenorrhea
5.2.2. Secondary Dysmenorrhea
5.2.3. Endometriosis
5.2.4. Adenomyosis
5.2.5. Uterine Myomas
5.2.6. Endometrial Polyps
5.2.7. Cervical Stenosis
5.2.8. Obstructive Malformations of Genital Tract
Chapter 6. Global Dysmenorrhea Treatment Market Size & Forecasts by Therapeutic Class 2022-2032
6.1. Segment Dashboard
6.2. Global Dysmenorrhea Treatment Market: Therapeutic Class Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.2.1. Non-Hormonal Medical Treatment
6.2.1.1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)
6.2.1.1.1. Non-Selective NSAIDS
6.2.1.1.2. Cox-2 Inhibitors
6.2.1.2. Transdermal Glyceryl Trinitrate
6.2.1.3. Over-The-Counter (OTC) Medications
6.2.2. Hormonal Medicine Treatment
6.2.2.1. Combined Oral Contraceptive
6.2.2.2. Progestin Regimens
6.2.2.3. Levonorgestrel Intrauterine System (LN-IUS)
6.2.3. Surgical Options
6.2.3.1. Laparoscopy
6.2.3.2. Hysterectomy
6.2.3.3. Presacral Neurectomy
6.2.3.4. Laparoscopic Uterosacral Nerve Ablation (LUNA)
6.2.3.5. Intrauterine Device (IUD)
Chapter 7. Global Dysmenorrhea Treatment Market Size & Forecasts by Region 2022-2032
7.1. North America Dysmenorrhea Treatment Market
7.1.1. U.S. Dysmenorrhea Treatment Market
7.1.1.1. Diseases breakdown size & forecasts, 2022-2032
7.1.1.2. Therapeutic Class breakdown size & forecasts, 2022-2032
7.1.2. Canada Dysmenorrhea Treatment Market
7.2. Europe Dysmenorrhea Treatment Market
7.2.1. U.K. Dysmenorrhea Treatment Market
7.2.2. Germany Dysmenorrhea Treatment Market
7.2.3. France Dysmenorrhea Treatment Market
7.2.4. Spain Dysmenorrhea Treatment Market
7.2.5. Italy Dysmenorrhea Treatment Market
7.2.6. Rest of Europe Dysmenorrhea Treatment Market
7.3. Asia-Pacific Dysmenorrhea Treatment Market
7.3.1. China Dysmenorrhea Treatment Market
7.3.2. India Dysmenorrhea Treatment Market
7.3.3. Japan Dysmenorrhea Treatment Market
7.3.4. Australia Dysmenorrhea Treatment Market
7.3.5. South Korea Dysmenorrhea Treatment Market
7.3.6. Rest of Asia Pacific Dysmenorrhea Treatment Market
7.4. Latin America Dysmenorrhea Treatment Market
7.4.1. Brazil Dysmenorrhea Treatment Market
7.4.2. Mexico Dysmenorrhea Treatment Market
7.4.3. Rest of Latin America Dysmenorrhea Treatment Market
7.5. Middle East & Africa Dysmenorrhea Treatment Market
7.5.1. Saudi Arabia Dysmenorrhea Treatment Market
7.5.2. South Africa Dysmenorrhea Treatment Market
7.5.3. Rest of Middle East & Africa Dysmenorrhea Treatment Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Pfizer Inc.
8.1.2. Bayer AG
8.1.3. Johnson & Johnson Services, Inc.
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Pfizer Inc.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Bayer AG
8.3.3. Johnson & Johnson Services, Inc.
8.3.4. Novartis AG
8.3.5. Abbott Laboratories
8.3.6. Merck & Co., Inc.
8.3.7. Sanofi S.A.
8.3.8. GlaxoSmithKline plc
8.3.9. Mylan N.V.
8.3.10. Teva Pharmaceutical Industries Ltd.
8.3.11. Zydus Cadila
8.3.12. Boehringer Ingelheim International GmbH
8.3.13. Ferring Pharmaceuticals
8.3.14. Endo Pharmaceuticals Inc.
8.3.15. Allergan plc
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes